The trademark application MAGNOLAI was filed by Eli Lilly and Company, a U.S. corporation (the "Applicant"). The application was published for oppositions on June 29, 2023, and it was registered by office on October 6, 2023 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 42 with following description of goods:
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Providing data captured from wearable biosensors in the field of pharmaceuticals and clinical trials
Providing medical and scientific research information
Clinical trials and providing information about their results.